Neurocrine Biosciences, Inc. (BIT:1NBIX)

Neurocrine Biosciences Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Oct 10, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Cap	11,658	11,677	11,192	9,919	6,956	7,713
Market Cap Growth	12.46%	4.33%	12.83%	42.60%	-9.81%	-9.64%
Enterprise Value	11,240	11,142	10,526	9,148	6,723	7,378
PE Ratio	39.31	41.49	53.34	76.56	92.58	23.04
Forward PE	15.32	18.15	21.34	22.53	24.55	22.30
PEG Ratio	-	0.37	0.37	0.37	0.37	0.37
PS Ratio	5.45	5.76	6.89	7.74	7.13	8.57
PB Ratio	5.08	5.24	5.83	6.75	5.88	7.96
P/TBV Ratio	4.50	5.47	5.96	6.92	6.07	8.32
P/FCF Ratio	-	24.35	35.96	35.70	34.67	41.19
P/OCF Ratio	-	22.79	33.35	33.96	31.51	39.22
EV/Sales Ratio	5.21	5.50	6.48	7.14	6.89	8.20
EV/EBITDA Ratio	22.42	21.67	44.94	40.17	68.89	49.96
EV/EBIT Ratio	26.18	22.69	48.75	42.69	76.21	52.60
EV/FCF Ratio	24.97	23.24	33.83	32.92	33.51	39.40
Debt / Equity Ratio	0.16	0.18	0.12	0.05	0.32	0.37
Debt / EBITDA Ratio	0.84	0.76	1.57	0.99	3.88	2.40
Debt / FCF Ratio	0.83	0.82	1.19	0.81	1.89	1.90
Asset Turnover	0.66	0.68	0.67	0.67	0.60	0.69
Inventory Turnover	0.66	0.71	1.08	0.71	0.49	0.45
Quick Ratio	2.88	3.06	2.25	2.49	3.65	5.14
Current Ratio	3.20	3.40	2.45	2.70	3.96	5.45
Return on Equity (ROE)	15.31%	15.70%	11.23%	8.03%	5.50%	52.39%
Return on Assets (ROA)	9.02%	11.84%	6.51%	7.58%	4.60%	30.71%
Return on Capital (ROIC)	14.91%	20.47%	12.37%	15.02%	9.21%	56.12%
Return on Capital Employed (ROCE)	15.10%	19.65%	11.33%	13.62%	6.07%	14.24%
Earnings Yield	2.54%	2.41%	1.87%	1.31%	1.08%	4.34%
FCF Yield	3.86%	4.11%	2.78%	2.80%	2.88%	2.43%
Buyback Yield / Dilution	-0.67%	1.31%	-0.50%	-0.39%	-0.34%	-0.32%
Total Shareholder Return	-	1.31%	-0.50%	-0.39%	-0.34%	-0.32%

Updated Jun 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.